A detailed history of Gould Capital, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Gould Capital, LLC holds 600 shares of CORT stock, worth $28,572. This represents 0.01% of its overall portfolio holdings.

Number of Shares
600
Previous 600 -0.0%
Holding current value
$28,572
Previous $15,000 26.67%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$21.1 - $27.46 $2,110 - $2,746
100 Added 20.0%
600 $15,000
Q4 2021

Feb 14, 2022

BUY
$17.1 - $23.34 $8,550 - $11,670
500 New
500 $10,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.1B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Gould Capital, LLC Portfolio

Follow Gould Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gould Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gould Capital, LLC with notifications on news.